mod\u00e8le GENEROUS<\/a>, l\u2019administration am\u00e9ricaine a lanc\u00e9 un projet pilote sur cinq ans qui vise \u00e0 assurer des prix \u00abjustes et raisonnables\u00bb pour le programme public Medicaid. \u00c0 l\u2019avenir, les prix pratiqu\u00e9s aux \u00c9tats-Unis doivent \u00eatre calcul\u00e9s sur la base des prix moyens de huit pays de comparaison, dont la Suisse. Les entreprises pharmaceutiques doivent divulguer leurs prix internationaux nets, y compris tous rabais et ristournes. Les autorit\u00e9s am\u00e9ricaines se basent sur ces donn\u00e9es pour abaisser les prix pratiqu\u00e9s aux \u00c9tats-Unis au niveau des pays o\u00f9 ils sont les plus bas.<\/p>\n\n\n\nLe mod\u00e8le GENEROUS pr\u00e9voit de calculer le prix net par substance active et de l\u2019aligner sur le pouvoir d\u2019achat de chaque pays. La liste des pays de comparaison (Canada, Danemark, France, Allemagne, Italie, Japon, Suisse, Royaume-Uni) reste stable pendant toute la dur\u00e9e du projet.<\/p>\n\n\n\n
Pour la Suisse, cela implique une pression consid\u00e9rable sur la fixation des prix. Si la Suisse sert de r\u00e9f\u00e9rence aux \u00c9tats-Unis, les m\u00e9dicaments ne seront plus propos\u00e9s dans notre pays qu\u2019\u00e0 des prix comparables \u00e0 ceux pratiqu\u00e9s outre-Atlantique, voire n\u2019arriveront plus sur le march\u00e9 ou seulement avec un long retard. En effet, les fabricants ne pourront pas proposer les m\u00e9dicaments \u00e0 des prix de r\u00e9f\u00e9rence comparativement bas dans de tr\u00e8s petits pays et faire ainsi baisser le prix dans le plus grand march\u00e9 au monde. \u00c0 la cl\u00e9, la formation de prix de r\u00e9f\u00e9rence \u00e0 l\u2019\u00e9chelon international menace la disponibilit\u00e9 de traitements innovants en Suisse.<\/p>\n\n\n\n
La Suisse se retrouve ainsi au c\u0153ur d\u2019une discussion mondiale sur les prix. La politique doit \u00e0 pr\u00e9sent agir pour assurer la s\u00e9curit\u00e9 d\u2019approvisionnement et l\u2019acc\u00e8s aux m\u00e9dicaments. Face \u00e0 la modification des conditions cadres mondiales, il est urgent de moderniser la fixation des prix pour les m\u00e9dicaments innovants, ainsi que de renoncer \u00e0 toute nouvelle mesure visant uniquement \u00e0 abaisser les co\u00fbts.<\/p>\n","protected":false},"excerpt":{"rendered":"
La Suisse devient pays de r\u00e9f\u00e9rence pour les prix des m\u00e9dicaments aux \u00c9tats-Unis. Un nouveau mod\u00e8le de l\u2019administration am\u00e9ricaine relie la formation des prix \u00e0 des moyennes internationales, dont les prix suisses en parit\u00e9 de pouvoir d\u2019achat. Ceci accro\u00eet la pression sur le syst\u00e8me suisse de formation des prix et menace la disponibilit\u00e9 de m\u00e9dicaments. […]<\/p>\n","protected":false},"author":1,"featured_media":3617,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"tags":[54,122,127,131],"class_list":["post-11956","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","tag-medien-fr","tag-communique-de-presse","tag-acces-des-patients","tag-politique"],"acf":[],"yoast_head":"\n
Communiqu\u00e9 de presse: La Suisse devient pays de r\u00e9f\u00e9rence pour les prix des m\u00e9dicaments aux \u00c9tats-Unis: il est urgent d\u2019agir - Interpharma<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-la-suisse-devient-pays-de-reference-pour-les-prix-des-medicaments-aux-etats-unis-il-est-urgent-dagir\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Communiqu\u00e9 de presse: La Suisse devient pays de r\u00e9f\u00e9rence pour les prix des m\u00e9dicaments aux \u00c9tats-Unis: il est urgent d\u2019agir\" \/>\n<meta property=\"og:description\" content=\"La Suisse devient pays de r\u00e9f\u00e9rence pour les prix des m\u00e9dicaments aux \u00c9tats-Unis. Un nouveau mod\u00e8le de l\u2019administration am\u00e9ricaine relie la formation des prix \u00e0 des moyennes internationales, dont les prix suisses en parit\u00e9 de pouvoir d\u2019achat. Ceci accro\u00eet la pression sur le syst\u00e8me suisse de formation des prix et menace la disponibilit\u00e9 de m\u00e9dicaments. […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-la-suisse-devient-pays-de-reference-pour-les-prix-des-medicaments-aux-etats-unis-il-est-urgent-dagir\/\" \/>\n<meta property=\"og:site_name\" content=\"Interpharma\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-11T10:25:08+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-03T09:23:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2025\/08\/iStock-1138801190_CH-USA.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1254\" \/>\n\t<meta property=\"og:image:height\" content=\"836\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"berta_admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@interpharma_ch\" \/>\n<meta name=\"twitter:site\" content=\"@interpharma_ch\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"berta_admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-la-suisse-devient-pays-de-reference-pour-les-prix-des-medicaments-aux-etats-unis-il-est-urgent-dagir\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-la-suisse-devient-pays-de-reference-pour-les-prix-des-medicaments-aux-etats-unis-il-est-urgent-dagir\/\"},\"author\":{\"name\":\"berta_admin\",\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/person\/1302f3da278bb3f8995756877d107818\"},\"headline\":\"Communiqu\u00e9 de presse: La Suisse devient pays de r\u00e9f\u00e9rence pour les prix des m\u00e9dicaments aux \u00c9tats-Unis: il est urgent d\u2019agir\",\"datePublished\":\"2025-11-11T10:25:08+00:00\",\"dateModified\":\"2026-03-03T09:23:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-la-suisse-devient-pays-de-reference-pour-les-prix-des-medicaments-aux-etats-unis-il-est-urgent-dagir\/\"},\"wordCount\":488,\"publisher\":{\"@id\":\"https:\/\/www.interpharma.ch\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-la-suisse-devient-pays-de-reference-pour-les-prix-des-medicaments-aux-etats-unis-il-est-urgent-dagir\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2025\/08\/iStock-1138801190_CH-USA.jpg\",\"keywords\":[\"M\u00e9dias\",\"Communiqu\u00e9 de presse\",\"Acc\u00e8s des patients\",\"Politique\"],\"inLanguage\":\"fr-FR\",\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\/\/www.interpharma.ch\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-la-suisse-devient-pays-de-reference-pour-les-prix-des-medicaments-aux-etats-unis-il-est-urgent-dagir\/\",\"url\":\"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-la-suisse-devient-pays-de-reference-pour-les-prix-des-medicaments-aux-etats-unis-il-est-urgent-dagir\/\",\"name\":\"Communiqu\u00e9 de presse: La Suisse devient pays de r\u00e9f\u00e9rence pour les prix des m\u00e9dicaments aux \u00c9tats-Unis: il est urgent d\u2019agir - Interpharma\",\"isPartOf\":{\"@id\":\"https:\/\/www.interpharma.ch\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-la-suisse-devient-pays-de-reference-pour-les-prix-des-medicaments-aux-etats-unis-il-est-urgent-dagir\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-la-suisse-devient-pays-de-reference-pour-les-prix-des-medicaments-aux-etats-unis-il-est-urgent-dagir\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2025\/08\/iStock-1138801190_CH-USA.jpg\",\"datePublished\":\"2025-11-11T10:25:08+00:00\",\"dateModified\":\"2026-03-03T09:23:36+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-la-suisse-devient-pays-de-reference-pour-les-prix-des-medicaments-aux-etats-unis-il-est-urgent-dagir\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-la-suisse-devient-pays-de-reference-pour-les-prix-des-medicaments-aux-etats-unis-il-est-urgent-dagir\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-la-suisse-devient-pays-de-reference-pour-les-prix-des-medicaments-aux-etats-unis-il-est-urgent-dagir\/#primaryimage\",\"url\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2025\/08\/iStock-1138801190_CH-USA.jpg\",\"contentUrl\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2025\/08\/iStock-1138801190_CH-USA.jpg\",\"width\":1254,\"height\":836},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-la-suisse-devient-pays-de-reference-pour-les-prix-des-medicaments-aux-etats-unis-il-est-urgent-dagir\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\/\/www.interpharma.ch\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Communiqu\u00e9 de presse: La Suisse devient pays de r\u00e9f\u00e9rence pour les prix des m\u00e9dicaments aux \u00c9tats-Unis: il est urgent d\u2019agir\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.interpharma.ch\/#website\",\"url\":\"https:\/\/www.interpharma.ch\/\",\"name\":\"Interpharma\",\"description\":\"Verband der forschenden Pharmazeutischen Firmen\",\"publisher\":{\"@id\":\"https:\/\/www.interpharma.ch\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.interpharma.ch\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.interpharma.ch\/#organization\",\"name\":\"Interpharma\",\"url\":\"https:\/\/www.interpharma.ch\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg\",\"contentUrl\":\"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg\",\"width\":\"1200\",\"height\":\"1200\",\"caption\":\"Interpharma\"},\"image\":{\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/interpharma_ch\",\"https:\/\/ch.linkedin.com\/company\/interpharma\",\"https:\/\/www.instagram.com\/interpharma_ch\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/person\/1302f3da278bb3f8995756877d107818\",\"name\":\"berta_admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g\",\"caption\":\"berta_admin\"},\"sameAs\":[\"https:\/\/interpharma.ch\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Communiqu\u00e9 de presse: La Suisse devient pays de r\u00e9f\u00e9rence pour les prix des m\u00e9dicaments aux \u00c9tats-Unis: il est urgent d\u2019agir - Interpharma","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-la-suisse-devient-pays-de-reference-pour-les-prix-des-medicaments-aux-etats-unis-il-est-urgent-dagir\/","og_locale":"fr_FR","og_type":"article","og_title":"Communiqu\u00e9 de presse: La Suisse devient pays de r\u00e9f\u00e9rence pour les prix des m\u00e9dicaments aux \u00c9tats-Unis: il est urgent d\u2019agir","og_description":"La Suisse devient pays de r\u00e9f\u00e9rence pour les prix des m\u00e9dicaments aux \u00c9tats-Unis. Un nouveau mod\u00e8le de l\u2019administration am\u00e9ricaine relie la formation des prix \u00e0 des moyennes internationales, dont les prix suisses en parit\u00e9 de pouvoir d\u2019achat. Ceci accro\u00eet la pression sur le syst\u00e8me suisse de formation des prix et menace la disponibilit\u00e9 de m\u00e9dicaments. […]","og_url":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-la-suisse-devient-pays-de-reference-pour-les-prix-des-medicaments-aux-etats-unis-il-est-urgent-dagir\/","og_site_name":"Interpharma","article_published_time":"2025-11-11T10:25:08+00:00","article_modified_time":"2026-03-03T09:23:36+00:00","og_image":[{"width":1254,"height":836,"url":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2025\/08\/iStock-1138801190_CH-USA.jpg","type":"image\/jpeg"}],"author":"berta_admin","twitter_card":"summary_large_image","twitter_creator":"@interpharma_ch","twitter_site":"@interpharma_ch","twitter_misc":{"\u00c9crit par":"berta_admin","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-la-suisse-devient-pays-de-reference-pour-les-prix-des-medicaments-aux-etats-unis-il-est-urgent-dagir\/#article","isPartOf":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-la-suisse-devient-pays-de-reference-pour-les-prix-des-medicaments-aux-etats-unis-il-est-urgent-dagir\/"},"author":{"name":"berta_admin","@id":"https:\/\/www.interpharma.ch\/#\/schema\/person\/1302f3da278bb3f8995756877d107818"},"headline":"Communiqu\u00e9 de presse: La Suisse devient pays de r\u00e9f\u00e9rence pour les prix des m\u00e9dicaments aux \u00c9tats-Unis: il est urgent d\u2019agir","datePublished":"2025-11-11T10:25:08+00:00","dateModified":"2026-03-03T09:23:36+00:00","mainEntityOfPage":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-la-suisse-devient-pays-de-reference-pour-les-prix-des-medicaments-aux-etats-unis-il-est-urgent-dagir\/"},"wordCount":488,"publisher":{"@id":"https:\/\/www.interpharma.ch\/#organization"},"image":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-la-suisse-devient-pays-de-reference-pour-les-prix-des-medicaments-aux-etats-unis-il-est-urgent-dagir\/#primaryimage"},"thumbnailUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2025\/08\/iStock-1138801190_CH-USA.jpg","keywords":["M\u00e9dias","Communiqu\u00e9 de presse","Acc\u00e8s des patients","Politique"],"inLanguage":"fr-FR","copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/www.interpharma.ch\/#organization"}},{"@type":"WebPage","@id":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-la-suisse-devient-pays-de-reference-pour-les-prix-des-medicaments-aux-etats-unis-il-est-urgent-dagir\/","url":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-la-suisse-devient-pays-de-reference-pour-les-prix-des-medicaments-aux-etats-unis-il-est-urgent-dagir\/","name":"Communiqu\u00e9 de presse: La Suisse devient pays de r\u00e9f\u00e9rence pour les prix des m\u00e9dicaments aux \u00c9tats-Unis: il est urgent d\u2019agir - Interpharma","isPartOf":{"@id":"https:\/\/www.interpharma.ch\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-la-suisse-devient-pays-de-reference-pour-les-prix-des-medicaments-aux-etats-unis-il-est-urgent-dagir\/#primaryimage"},"image":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-la-suisse-devient-pays-de-reference-pour-les-prix-des-medicaments-aux-etats-unis-il-est-urgent-dagir\/#primaryimage"},"thumbnailUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2025\/08\/iStock-1138801190_CH-USA.jpg","datePublished":"2025-11-11T10:25:08+00:00","dateModified":"2026-03-03T09:23:36+00:00","breadcrumb":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-la-suisse-devient-pays-de-reference-pour-les-prix-des-medicaments-aux-etats-unis-il-est-urgent-dagir\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-la-suisse-devient-pays-de-reference-pour-les-prix-des-medicaments-aux-etats-unis-il-est-urgent-dagir\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-la-suisse-devient-pays-de-reference-pour-les-prix-des-medicaments-aux-etats-unis-il-est-urgent-dagir\/#primaryimage","url":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2025\/08\/iStock-1138801190_CH-USA.jpg","contentUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2025\/08\/iStock-1138801190_CH-USA.jpg","width":1254,"height":836},{"@type":"BreadcrumbList","@id":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-la-suisse-devient-pays-de-reference-pour-les-prix-des-medicaments-aux-etats-unis-il-est-urgent-dagir\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/www.interpharma.ch\/fr\/"},{"@type":"ListItem","position":2,"name":"Communiqu\u00e9 de presse: La Suisse devient pays de r\u00e9f\u00e9rence pour les prix des m\u00e9dicaments aux \u00c9tats-Unis: il est urgent d\u2019agir"}]},{"@type":"WebSite","@id":"https:\/\/www.interpharma.ch\/#website","url":"https:\/\/www.interpharma.ch\/","name":"Interpharma","description":"Verband der forschenden Pharmazeutischen Firmen","publisher":{"@id":"https:\/\/www.interpharma.ch\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.interpharma.ch\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.interpharma.ch\/#organization","name":"Interpharma","url":"https:\/\/www.interpharma.ch\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/","url":"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg","contentUrl":"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg","width":"1200","height":"1200","caption":"Interpharma"},"image":{"@id":"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/interpharma_ch","https:\/\/ch.linkedin.com\/company\/interpharma","https:\/\/www.instagram.com\/interpharma_ch\/"]},{"@type":"Person","@id":"https:\/\/www.interpharma.ch\/#\/schema\/person\/1302f3da278bb3f8995756877d107818","name":"berta_admin","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g","caption":"berta_admin"},"sameAs":["https:\/\/interpharma.ch"]}]}},"_links":{"self":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts\/11956","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/comments?post=11956"}],"version-history":[{"count":1,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts\/11956\/revisions"}],"predecessor-version":[{"id":11957,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts\/11956\/revisions\/11957"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/media\/3617"}],"wp:attachment":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/media?parent=11956"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/tags?post=11956"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}